advertisement
Lu DW 90
Showing records 1 to 25 | Display only abstracts from Lu DW in IGR 25-1124419 Activation of the ROCK/MYLK Pathway Affects Complex Molecular and Morphological Changes of the Trabecular Meshwork Associated With Ocular Hypertension
Hsu CC
Investigative Ophthalmology and Visual Science 2024; 65: 17 (IGR: 25-1)
119183 Unveiling Novel Structural Biomarkers for the Diagnosis of Glaucoma
Tsai YC
Biomedicines 2024; 12: (IGR: 25-1)
120025 The Application of Rho Kinase Inhibitors in the Management of Glaucoma
Liu LC
International journal of molecular sciences 2024; 25: (IGR: 25-1)
118993 Glaucoma: Current and New Therapeutic Approaches
Lee HP
Biomedicines 2024; 12: (IGR: 25-1)
124419 Activation of the ROCK/MYLK Pathway Affects Complex Molecular and Morphological Changes of the Trabecular Meshwork Associated With Ocular Hypertension
Lin FP
Investigative Ophthalmology and Visual Science 2024; 65: 17 (IGR: 25-1)
118993 Glaucoma: Current and New Therapeutic Approaches
Tsung TH
Biomedicines 2024; 12: (IGR: 25-1)
120025 The Application of Rho Kinase Inhibitors in the Management of Glaucoma
Chen YH
International journal of molecular sciences 2024; 25: (IGR: 25-1)
119183 Unveiling Novel Structural Biomarkers for the Diagnosis of Glaucoma
Lee HP
Biomedicines 2024; 12: (IGR: 25-1)
118993 Glaucoma: Current and New Therapeutic Approaches
Tsai YC
Biomedicines 2024; 12: (IGR: 25-1)
124419 Activation of the ROCK/MYLK Pathway Affects Complex Molecular and Morphological Changes of the Trabecular Meshwork Associated With Ocular Hypertension
Tseng HC
Investigative Ophthalmology and Visual Science 2024; 65: 17 (IGR: 25-1)
119183 Unveiling Novel Structural Biomarkers for the Diagnosis of Glaucoma
Tsung TH
Biomedicines 2024; 12: (IGR: 25-1)
120025 The Application of Rho Kinase Inhibitors in the Management of Glaucoma
Lu DW
International journal of molecular sciences 2024; 25: (IGR: 25-1)
119183 Unveiling Novel Structural Biomarkers for the Diagnosis of Glaucoma
Chen YH
Biomedicines 2024; 12: (IGR: 25-1)
124419 Activation of the ROCK/MYLK Pathway Affects Complex Molecular and Morphological Changes of the Trabecular Meshwork Associated With Ocular Hypertension
Ho PK
Investigative Ophthalmology and Visual Science 2024; 65: 17 (IGR: 25-1)
118993 Glaucoma: Current and New Therapeutic Approaches
Chen YH; Lu DW
Biomedicines 2024; 12: (IGR: 25-1)
119183 Unveiling Novel Structural Biomarkers for the Diagnosis of Glaucoma
Lu DW
Biomedicines 2024; 12: (IGR: 25-1)
124419 Activation of the ROCK/MYLK Pathway Affects Complex Molecular and Morphological Changes of the Trabecular Meshwork Associated With Ocular Hypertension
Chen YG; Lu DW; Chen YH; Chou JL; Chen HC; Huang YC
Investigative Ophthalmology and Visual Science 2024; 65: 17 (IGR: 25-1)
117535 Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial
Wang TH
Clinical Ophthalmology 2024; 18: 2093-2106 (IGR: 24-4)
116828 The Role of Retinal Ganglion Cell Structure and Function in Glaucoma
Feng KM
Cells 2023; 12: (IGR: 24-4)
118116 A multi-label transformer-based deep learning approach to predict focal visual field progression
Chen L; Tseng VS
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 2227-2235 (IGR: 24-4)
117535 Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial
Aung T
Clinical Ophthalmology 2024; 18: 2093-2106 (IGR: 24-4)
116828 The Role of Retinal Ganglion Cell Structure and Function in Glaucoma
Tsung TH
Cells 2023; 12: (IGR: 24-4)
118116 A multi-label transformer-based deep learning approach to predict focal visual field progression
Tsung TH
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 2227-2235 (IGR: 24-4)
116828 The Role of Retinal Ganglion Cell Structure and Function in Glaucoma
Chen YH
Cells 2023; 12: (IGR: 24-4)
117535 Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial
Lu DW
Clinical Ophthalmology 2024; 18: 2093-2106 (IGR: 24-4)
